Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) will host a virtual investor call on October 11 to update on its latest Phase I/II BEXMAB data for treating acute myeloid leukaemia and myelodysplastic syndrome. It will take place at 08.00 EST/13.00 BST/15.00 EEST. To register click here.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com